Features
The Effect of GLP-1RAs in Diabetic Retinopathy
Real-world studies present mixed evidence on the link between GLP-1RA use and DR progression.
By Julia H. Joo, MD, MPH, Aleksandra V. Rachitskaya, MD, FASRS
History and Current Directions of the DRCR Retina Network
More than 2 decades of rigorous and collaborative research have defined treatment paradigms for the management of retinal diseases.
By Noam D. Rudnick, MD, PhD, Kevin J. Blinder, MD, FASRS, Scott M. Friedman, MD, et al.
Remote OCT Protocol to Speed Diagnosis and Treatment of CRAO
A remote consult protocol shows improvement in time to treatment and visual outcomes after eye stroke.
By Keva Li, BS, GARETH M.C. LEMA, MD, PHD
AI-READI: A Multimodal Data Set for Diabetic Eye Research
An NIH-funded project is redefining how artificial intelligence can support ophthalmic research in type 2 diabetes.
By Aaron Y. Lee, MD, MSCI, Nayoon Gim, BS
Departments
Collaboration in Retina
Upfront: Working together to share knowledge and insights brings the retina community closer.
By Diana V. Do, MD
How Vorolanib Could Shift the DME Landscape
Clinical Trial Download: Phase 2 VERONA data highlight extended durability and visual gains with sustained-release intravitreal TKI delivery.
By Yasha Modi, MD , Ashkan M. Abbey, MD, Jay S. Duker, MD, et al.
Coding Diabetic Patients With Ophthalmic Complications
Coding Q&A: Paying attention to the details ensures accurate ICD-10 coding for diabetic eye conditions.
By Elizabeth Cifers, MBA, MSW, CHC, CPC
Building a Vitreoretinal Surgical Practice
Early Career Perspectives in Retina: Here are some strategies for navigating the transition to independent surgery, building your referral base, and learning from complications.
By Mrinali Gupta, MD, FASRS
Clinical Trial Update June 2025
Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.
News
GLP-1 Receptor Agonists Linked to Increased nAMD Risk
Data from a Canadian study highlights the potential ocular risks of GLP-1 RA medications.
EBNA-1 Antibody Response Linked to Uveitis
New data connect EBV peptide, HLA-DRB1*15:01, and autoimmune eye inflammation in children.
By Sarah Fackler, staff writer
Study Finds Blocking Prox1 Transfer Promotes Retinal Regeneration
Inhibiting protein transfer enables Müller glia to reenter cell cycle and regenerate neurons in mouse models.
OCT Biomarkers Predict Anti-VEGF Failure in DME
Further studies are needed to bolster certainty, but confirmation could save injections in insufficient responders.
By Sarah Fackler, staff writer
High and Low HDL Levels Associated With AMD Risk
Researchers also identified associated genes and hypothesized a mechanism of drusenogenesis with Lp(a).
By Sarah Fackler, staff writer
Implant May Modify DR Progression
PER-001 is being developed for long-term control of diabetic retinopathy by addressing underlying ischemia.
Trial Data Indicates Cell Therapy May Reverse GA Damage
Surgical delivery of OpRegen RPE cell therapy produced sustained anatomical and functional improvements in geographic atrophy, according to 36-month data.
By Jim Gallagher, senior managing editor
In Memoriam: Jerry A. Shields, MD
A founder of modern ocular oncology, Dr. Shields helped transform eye cancer care through innovation, research, and mentorship.
Supported Content
Peer Perspectives: Advances in Macular Telangiectasia Type 2 Care
Our experts walk through the hallmark features and diagnostic challenges of MacTel.
By Sophie J. Bakri, MD, MBA, Roger A. Goldberg, MD, MBA
Articles
Preservation of Vision in GA in ARCHER Trial Continues Evaluation in ARCHER II
The first known clinically meaningful preservation of vision in GA.
By Priya Vakharia, MD, Michael A. Singer, MD